Peripheral blood mononuclear cells (PBMCs) were collected from a patient with treatment-refractory Schizophrenia who presented an exceptional clinical response to Clozapine. iPSC lines were established with a non-integrating reprogramming system based on Sendai virus. A footprint-free hiPSC line was characterized to confirm the expression of the main endogenous pluripotency markers and have a regular karyotype. Pluripotency was confirmed by differentiation into cells belonging to the three germ layers. This hiPSC line represents a valuable tool to study the molecular, biochemical and electrophysiological properties of mature neuronal populations belonging to Clozapine responder patients with a severe form of Schizophrenia.
Resource details
Blood sample was collected by a 40-year old male patient with a diagnosis of treatment-refractory Schizophrenia at the Department of Mental Health of the San Paolo Hospital, Milan (Italy). The diagnosis of Schizophrenia was confirmed by the assessment of two independent psychiatrists with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I).
According to specific criteria (Caspi et al., 2004) , the treatment-resistance to conventional antipsychotics justified the introduction of Clozapine which resulted in an extraordinary clinical response. Indeed, the patient underwent multiple hospitalizations for approximately a decade after onset of symptoms associated with a marked psychosocial impairment. After stabilization on Clozapine, the patient was never again hospitalized and satisfied specific criteria for full recovery from Schizophrenia (Jaaskelainen et al., 2013) .
To generate the SCZ#4-9 iPSC line, an integration-free gene delivery method (CytoTune™-iPS 2.0 Sendai Reprogramming Kit; Thermo Fischer Scientific) of the four Yamanaka reprogramming factors OCT4, SOX2, KLF4, and C-MYC (Takahashi et al., 2007) based on Sendai viral Stem Cell Research 17 (2016) 
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Stem Cell Research j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / s c r particles (Fusaki et al., 2009; Yang et al., 2008 Yang et al., -2012 was used. iPSC-like colonies appeared after 10-12 days and were picked one week later (Fig. 1A) . One of the selected clones gave rise to the established SCZ#4-9 iPSC line with a characteristic iPSC-like morphology ( Fig. 1A ) and specific immunoreactivity for OCT4, SOX2 and TRA1-60 pluripotency-associated markers (Fig. 1A) . PCR ( Fig. 1B ) and Western Blot ( Fig. 1C ) analyses confirmed the expression of pluripotency transcripts. SCZ#4-9 iPSC line displayed a normal diploid 46, XY karyotype, without noticeable abnormalities (Fig. 1B) . The expression of Sendai virus genome in cultures at passage 0 and passage 10 was analyzed by PCR and the loss of the viral genome was confirmed in passage 10 SCZ#4-9 iPSCs (Fig. 1B) . Embryoid body assay was performed to assess the pluripotent competence SCZ#4-9 iPSC line. Cells were cultured for one week in EB suspension and for additional 7 days in adhesion to promote the in vitro maturation towards the three germ layer derivatives (Carpenter et al., 2003) . EBs cultures at 14 days displayed the presence of differentiated cells immunoreactive for ectodermal (β3-Tubulin), mesodermal (α-SMA) and endodermal (AFP) markers ( Fig. 2A) . The differentiation competency of SCZ#4-9 iPSCs was comparable to that observed for a commercial hiPSC line, as shown by the similar expression levels of transcripts for FGF5 (ectoderm marker), Nestin (neuro-ectoderm marker), T-Brachyury (mesoderm marker), SOX-17 (endoderm marker) assessed by qRT-PCR (Fig. 2B ).
Materials and methods

PBMCs collection and freezing
Peripheral Blood Mononuclear Cells (PBMCs) from patients were isolated in BD Vacutainer CPT Cell Preparation tubes with sodium citrate, after 30 min centrifugation (1800 × g at room temperature). PBMCs were collected in PBS for a total volume of 35 ml and centrifuged at 300 ×g for 15 min RT and resuspended in fetal bovine serum (FBS) with 10% DMSO. 2 × 10 6 cells were aliquoted and frozen.
PBMCs thawing and reprogramming with Sendai virus particles
PBMCs were thawed at 37°C and centrifuged at 200 ×g for 10 min in expansion medium (EM) made of StemPro-34 Serum Free Medium (SFM, Thermo Fisher Scientific) Basal Medium, StemPro-34 Nutrient Supplement, 200 mM GlutaMAX, 1% Penicillin/Streptomycin, 100 ng/ml Stem Cell Factor (SCF, Prepotech), 100 ng/ml FLT-3 (Thermo Fisher Scientific), 20 ng/ml Interleukin-6 (IL-6) (Thermo Fisher Scientific), 20 ng/ml Interleukin-3 (IL-3) (Thermo Fisher Scientific). The medium was replaced daily for the following 3 days.
In order to deliver reprogramming genes in PBMCs, viral particles provided with the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific) were used following the manufacturer's protocol. Three weeks post-transduction colonies with iPSCs morphology appeared and were picked, transferred onto a new well and cultured on Geltrex-coated plastic dish in E8 according to the manufacture's protocol.
In vitro differentiation
Embryoid body (EB) formation assay was performed by gently resuspending iPSCs clumps in 100-mm non-tissue culture-treated dish in Essential 6 medium (E6 medium; Thermo Fisher Scientific). Medium was changed daily. At day 7, EBs were collected and plated on Geltrexcoated dishes in E6 medium to allow growth in adhesion for further 7 days. Medium was changed every other day.
RNA isolation, polymerase chain reaction (PCR) and quantitative-PCR (qPCR)
RNA was isolated with the TRIzol Reagent (Thermo Fisher Scientific) following the manufacture's protocol and reverse transcribed using iScript cDNA Synthesis Kit (BioRad). Transcripts of interest were amplified using EURO TAQ Thermostable DNA polymerase (EUROCLONE) and detection of genes of interest was confirmed with specific primes (Table  1) . Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was performed using the SsoAdvanced Universal SYBR Green Supermix Kit following the manufacturer's instructions. Betaactin was used as housekeeping gene to normalize data. Amplification was performed on a CFX96 BioRad RealTime PCR machine. Results were analyzed with BioRad CFX Manager dedicated software.
Immunofluorescence assay
Cells were fixed with PFA 4% for 15 min RT, permeabilized with Triton 0.5% for 15 min RT and blocked with blocking solution (10% FBS in PBS) for 1 h RT. Cultures were then incubated with specific primary antibodies overnight at 4°C (Table 2 ) and stained for 45 min at RT with secondary antibody and Hoechst 33,258 1 μg/ml (Thermo Fischer Scientific). Images were detected with the microscope Leica DM IL Led Fluo with Leica DFC450 C camera (Leica Microsystem).
Western blot assay
Cultures were lysated in SDS Sample Buffer (62.5 mM Tris-HCl ph 6.8; 2% SDS; 10% Glycerol; 50 mM DTT; Bromophenol Blue). Samples were boiled at 95°C for 5 min and loaded in the 8% polyacrylamide gel and proteins blotted on a PVDF membrane by means of Trans Blot Turbo apparatus (BioRad). Primary antibodies (Table 2) were incubated overnight at 4°C in agitation and secondary antibody for 45 min at RT. Signal was detected with the ECL Clarity system (BioRad) in dark chamber UVITECH Cambridge (Uvitech) and Uvitech software was used to acquire and analyze the data.
Karyotyping
Cell cultures were treated with colcemid (Gibco KaryoMAX Colcemid solution in PBS, Thermo Fischer Scientific) at a final 
